The ARHGEF39 gene helps switch on signals that let cells change shape, move, and communicate. If it does not work as expected, cells may struggle to organize their inner support structure and respond normally to growth signals. Researchers are studying whether certain variants in this gene may play a role in cancer and other conditions.
What is a gene?
Genes are stretches of DNA that give your cells instructions to make molecules or regulate processes in the body. Some genes provide the code for proteins, which are the parts of cells that do the work. Others are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
ARHGEF39Gene function
What if the gene works
The ARHGEF39 gene helps cells control shape, movement, and internal signaling. It does this by turning on proteins that guide the cell’s internal skeleton and support everyday cell communication.
Risk
What if the gene does not work
Variants in the ARHGEF39 gene may weaken or disrupt signals that help cells organize their internal skeleton and movement. Milder and more severe variants can reduce this signaling to different degrees, which can change how strongly the protein works.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the ARHGEF39 gene is currently established. Early cancer research is exploring whether the ARHGEF39 gene could serve as a biomarker or drug target, but this has not changed routine care.
Gene function
What if the gene works
The ARHGEF39 gene helps cells control their inner support system and movement signals. It works by turning on small protein switches that guide shape, attachment, and motion. Understanding what the ARHGEF39 gene does in cells helps explain how tissues stay organized during normal growth and renewal.
The ARHGEF39 gene helps switch on certain Rho family proteins, which are small signaling proteins inside cells. This starts messages that guide how cells change shape and respond to their surroundings.
By activating these signals, this gene helps organize the actin cytoskeleton (the cell's inner support framework). That lets cells keep their structure and make controlled shape changes when needed.
Through its protein, the ARHGEF39 gene supports the careful steps cells use to spread, attach, and move. These actions are part of normal tissue growth, repair, and everyday cell turnover.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the ARHGEF39 gene can alter the protein’s shape, stability, or ability to interact with signaling partners inside cells. Research on how ARHGEF39 gene variants affect protein function suggests that milder changes may partly reduce activity, while more disruptive variants can shorten the protein or lower how much of it the cell makes. This can change cell signaling to different degrees, rather than having just one level of impact.
How variants are linked to conditions
At this time, the ARHGEF39 gene does not yet have a broadly confirmed link to a specific health condition, and research on how ARHGEF39 gene variants are linked to conditions is still developing. Anyone with a confirmed ARHGEF39-related diagnosis should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ARHGEF39 gene. If ARHGEF39 is part of your test results and you have concerns about what it may mean for you or your family, a doctor or genetic counselor can help put it in context.
Inheritance of ARHGEF39 variants
There is not yet a broadly confirmed, disease-specific inheritance pattern for ARHGEF39 gene variants, so how ARHGEF39 gene variants are inherited in relation to a defined genetic condition remains uncertain. The ARHGEF39 gene is located on chromosome 9, which is an autosome rather than a sex chromosome. That means each person usually inherits one copy of the ARHGEF39 gene from each parent.
What does my ARHGEF39 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for ARHGEF39, although this may become clearer as research grows. If you have a specific ARHGEF39 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can review the exact finding in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
ARHGEF39 genetic testing looks for variants by reading your DNA from a blood sample, saliva, or a cheek swab. A lab compares the ARHGEF39 gene with a reference sequence and reports any changes it finds. Results may show a benign variant, a variant of uncertain significance, or a variant linked to health.
When should I consider getting a genetic test?
There is not yet a broadly established, ARHGEF39-specific reason for genetic testing in routine care. Decisions about testing are usually based on symptoms, family history, and the broader question a doctor or genetic counselor is trying to answer.
A genetic result is only one part of your health story
Genetic findings can be informative, although what they can tell you varies with the condition and the specific kind of variant. Over time, the body is shaped by many factors, including lifestyle, environment, age, and medical history. With some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can influence how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can shape both how much benefit a medicine gives and how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medication. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug affects the body or how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the ARHGEF39 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response. General questions about your health, new symptoms, side effects, or how a medicine may affect you are best discussed with your doctor or pharmacist.
History
ARHGEF39 does not have the kind of public profile seen with genes such as BRCA1 or APOE, but its history reflects the steady progress of modern genetics. Initially understood only through visible traits, later recognized as tied to a specific gene, many genes like ARHGEF39 were first cataloged during large genome mapping efforts in the early 2000s. Researchers then refined its name and classification as more sequence data became available and as its place within a broader gene family became clearer. From these first observations, research expanded steadily, with later studies examining ARHGEF39 in relation to cell signaling and some cancer findings.